Literature DB >> 12205640

Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

Erik J Uhlmann1, Michael Wong, Rebecca L Baldwin, M Livia Bajenaru, Hiroaki Onda, David J Kwiatkowski, Kelvin Yamada, David H Gutmann.   

Abstract

Persons affected with tuberous sclerosis complex (TSC) develop a wide range of neurological abnormalities including aberrant neuronal migration and seizures. In an effort to model TSC-associated central nervous system abnormalities in mice, we generated two independent lines of astrocyte-specific Tsc1 conditional knockout mice by using the Cre-LoxP system. Astrocyte-specific Tsc1-null mice exhibit electroencephalographically proven seizures after the first month of age and begin to die at 3 to 4 months. Tsc1-null mice show significant increases in astrocyte numbers throughout the brain by 3 weeks of age and abnormal neuronal organization in the hippocampus between 3 and 5 weeks. Moreover, cultured Tsc1-null astrocytes behave similar to wild-type astrocytes during log phase growth but demonstrate increased saturation density associated with reduced p27(Kip1) expression. Collectively, our results demonstrate that astrocyte-specific disruption of Tsc1 in mice provides a context-dependent growth advantage for astrocytes that results in abnormalities in neuronal organization and epilepsy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205640     DOI: 10.1002/ana.10283

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  169 in total

1.  A Tuber-ful Animal Model of Tuberous Sclerosis At Last?

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

2.  Regulation of mast cell survival and function by tuberous sclerosis complex 1.

Authors:  Jinwook Shin; Hongjie Pan; Xiao-Ping Zhong
Journal:  Blood       Date:  2012-02-23       Impact factor: 22.113

3.  Tuber-Less Models of Tuberous Sclerosis Still Provide Insights Into Epilepsy.

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

4.  Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Yannan Ouyang; Vered Gazit; John R Cirrito; Laura A Jansen; Kevin C Ess; Kelvin A Yamada; David F Wozniak; David M Holtzman; David H Gutmann; Michael Wong
Journal:  Neurobiol Dis       Date:  2007-07-21       Impact factor: 5.996

Review 5.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

6.  The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Lirong Han; Brennan Beeler; Joseph L Friedman; Elizabeth Griffin; Yue-Shan Piao; Nicholas R Rensing; Michael Wong
Journal:  Epilepsia       Date:  2018-08-05       Impact factor: 5.864

7.  Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome.

Authors:  Wei-Hsiang Huang; Casey J Guenthner; Jin Xu; Tiffany Nguyen; Lindsay A Schwarz; Alex W Wilkinson; Or Gozani; Howard Y Chang; Mehrdad Shamloo; Liqun Luo
Journal:  Neuron       Date:  2016-09-29       Impact factor: 17.173

Review 8.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

9.  RNA Polymerase 1 Is Transiently Regulated by Seizures and Plays a Role in a Pharmacological Kindling Model of Epilepsy.

Authors:  Aruna Vashishta; Lukasz P Slomnicki; Maciej Pietrzak; Scott C Smith; Murali Kolikonda; Shivani P Naik; Rosanna Parlato; Michal Hetman
Journal:  Mol Neurobiol       Date:  2018-03-15       Impact factor: 5.590

10.  Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons.

Authors:  Stephan Rüegg; Marianna Baybis; Hal Juul; Marc Dichter; Peter B Crino
Journal:  Epilepsy Res       Date:  2007-11-05       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.